Studies of Sulfur Metabolism in Humans
Completed · Early Phase 1
Conditions studied: Metabolic Side Effects of Drugs
In brief
The study test whether the NSAID allosteric site of human sulfotransferase 1A1 (SULT1A1) is operative in humans. The study will test the effects of mefenamic acid (MEF) on the sulfonation of acetaminophen (APAP, a SULT1A1 specific substrate) and dehydroepiandrosterone (DHEA, a SULT2A1 substrate). If the allosteric site is active in vivo, MEF is predicted to result in a decrease in sulfonation of APAP (MEF inhibits SULT with high affinity (Ki = 23 nM), and to have no effect on sulfonation of the DHEA (MEF has little or no effect on SULT2A1 activity).
Key facts
- Study ID
- NCT03383133
- Run by
- Albert Einstein College of Medicine
- People needed
- 1
- Starts
- 2018-01-11
- Expected to finish
- 2023-02-02
- Last updated by the study team
- 2023-10-27
Who can join
Age: 61 and older, up to 61. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Gender - one male
- Age - 61 y.o.
- Healthy
- Agreed to sign the consent form
You may not qualify if…
- ● None
Where it is running
- Albert Einstein Collage of Medicine — The Bronx, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.